News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Performance-based Pathology Part A Agreements Are Win-Win with Hospitals

Pathologists find new Part A contract model creates added value for hospitals

Now pathologists have a new approach to reverse the trend for hospitals and health systems to pay even less for Part A pathology professional services. Innovative pathologists are crafting what they call a “performance-based Part A Support” agreement that adds new value for the hospital, along with additional compensation for the pathologists.

For pathologists, this is a major breakthrough in stabilizing and increasing hospital compensation for these important services. After all, for most of the past decade, many hospitals arbitrarily cut reimbursement for Part A pathology professional services—even as these hospitals held pathologists to ever-higher standards, including improved patient outcomes and more resources devoted to patient safety in the hospital’s clinical laboratory.

(more…)

Yokohama’s Cherry Blossom Symposium Showcases Clinical Lab Automation Breakthroughs

Third-generation total laboratory automation (TLA) solutions now used by Japanese clinical labs

Your Dark Daily editor is writing this e-briefing from the 7th Cherry Blossom Symposium in Japan, where it is already Saturday—one day ahead of you readers in North America! The second day of this International Conference of Clinical Laboratory Automation and Robotics is now unfolding.

Yesterday’s opening sessions were chock-full of innovation, insights, and new developments in clinical laboratory automation and robotics. Representing 12 nations, a sizeable crowd of 260 pathologists, clinical biochemists, laboratory scientists, and in vitro diagnostics (IVD) vendors is in attendance.

(more…)

Pathology Companies Leica and Omnyx Beef Up Their Access to Digital Pathology Technology

Leica Microsystem acquires Genetix while Omnyx licenses patents from Olympus

More pathology laboratories are acquiring and deploying digital scanners and digital pathology systems. In response to the growing demand for digital pathology solutions, several prominent companies are extending their capabilities in virtual microscope slide technology. Over recent months, an acquisition and a licensing deal provide examples of the intense activity in the digital pathology marketplace.

The acquisition was done by Leica Microsystem, Inc., of Wetzlar, Germany. On March 10th, it announced its acquisition of Genetix, Ltd., based in New Milton, UK. The licensing deal involved Omnyx, LLC, of Pittsburgh, Pennsylvania, in an agreement that gives it access to certain patents held by Olympus Corporation. Both of these transactions occurred in March. Each was motivated by initiating the company’s need to further develop its technologies in support of whole slide imaging (WSI) and digital pathology systems.

(more…)

LabCorp’s King and Ventana Medical Systems’ Grogan to Assess Clinical Laboratory Industry’s Future

Pathologists and clinical lab executives will hear perspectives from 80 speakers at the upcoming Executive War College on Lab and Pathology Management

For any pathologist or clinical laboratory executive interested in the future of the lab testing industry, there will be plenty of insights at the upcoming 15th Annual Executive War College on Laboratory and Pathology Management April 27-28 at the New Orleans Sheraton Hotel.  Leading a line-up of 80 speakers are David King, CEO of Laboratory Corporation of America (NYSE: LH) and Thomas Grogan, M.D., Founder and Chief Scientific Advisor of Roche Ventana Medical Systems.

There’s lots of optimism about the future of laboratory testing. That’s because genetic and molecular testing is giving pathologists new tools to more precisely diagnose disease and determine appropriate therapies. LabCorp’s David King, will speak to how lab test data is the linchpin in the drive to more tightly integrate clinical care in ways to lift patient outcomes.

(more…)

Cuts in Health Budgets Are Threat and Opportunity for Clinical Pathology Laboratories

Some clinical labs use new pathology lab test technologies to deliver added value to physicians, patients, and payers

Clinical pathology laboratories in the United States and other developed countries across the globe face an unprecedented double-whammy. On one hand, the ongoing explosion of genetic and molecular knowledge gives pathologists and clinical laboratories incredible new tools for diagnosing disease and guiding therapy.

On the other hand, funding for government health programs in the United States and other developed countries is failing to keep pace with demand for health services and the need to pay for all the sophisticated molecular diagnostics and complex therapies now coming to market.

(more…)

;